These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 17979650)

  • 21. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
    Al Asmari AK; Ullah Z; Tariq M; Fatani A
    Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of drug-to-lipid ratio to the development of optimized liposomal formulation.
    Chountoulesi M; Naziris N; Pippa N; Demetzos C
    J Liposome Res; 2018 Sep; 28(3):249-258. PubMed ID: 28627268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomes in ultrasonic drug and gene delivery.
    Huang SL
    Adv Drug Deliv Rev; 2008 Jun; 60(10):1167-76. PubMed ID: 18479776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updates on the use of liposomes for active tumor targeting in cancer therapy.
    Yan W; Leung SS; To KK
    Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of liposomal formulations for cell targeting.
    Nogueira E; Gomes AC; Preto A; Cavaco-Paulo A
    Colloids Surf B Biointerfaces; 2015 Dec; 136():514-26. PubMed ID: 26454541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs.
    Song G; Wu H; Yoshino K; Zamboni WC
    J Liposome Res; 2012 Sep; 22(3):177-92. PubMed ID: 22332871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.
    Goren D; Horowitz AT; Zalipsky S; Woodle MC; Yarden Y; Gabizon A
    Br J Cancer; 1996 Dec; 74(11):1749-56. PubMed ID: 8956788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new method for liposome preparation using a membrane contactor.
    Jaafar-Maalej C; Charcosset C; Fessi H
    J Liposome Res; 2011 Sep; 21(3):213-20. PubMed ID: 20860451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposomes as biocompatible and smart delivery systems - the current state.
    Dymek M; Sikora E
    Adv Colloid Interface Sci; 2022 Nov; 309():102757. PubMed ID: 36152374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
    Schroeder A; Kost J; Barenholz Y
    Chem Phys Lipids; 2009 Nov; 162(1-2):1-16. PubMed ID: 19703435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of gemcitabine liposome injections.
    Zhou Q; Liu L; Zhang D; Fan X
    Pharmazie; 2012 Oct; 67(10):844-7. PubMed ID: 23136718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
    Ranade VV
    J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs.
    Joshi S; Hussain MT; Roces CB; Anderluzzi G; Kastner E; Salmaso S; Kirby DJ; Perrie Y
    Int J Pharm; 2016 Nov; 514(1):160-168. PubMed ID: 27863660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of bioactive transfer through liposomal bilayers.
    Maherani B; Arab-Tehrani E; Linder M
    Curr Drug Targets; 2011 Apr; 12(4):531-45. PubMed ID: 20863276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From conventional to stealth liposomes: a new Frontier in cancer chemotherapy.
    Cattel L; Ceruti M; Dosio F
    J Chemother; 2004 Nov; 16 Suppl 4():94-7. PubMed ID: 15688621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.